Skip to main content
Log in

GSK accused of pay-for-delay deals in the UK

  • News item
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Dyer C. GSK paid smaller companies to delay generic versions of paroxetine, says fair trade body. BMJ 346: 22 Apr 2013. Available from: URL: http://dx.doi.org/10.1136/bmj.f2566

Download references

Additional information

* Alpharma, Generics UK, and Norton Healthcare

** see PharmacoEconomics & Outcomes News 675 p1; 803085376

Rights and permissions

Reprints and permissions

About this article

Cite this article

GSK accused of pay-for-delay deals in the UK. PharmacoEcon Outcomes News 677, 2 (2013). https://doi.org/10.1007/s40274-013-0341-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-013-0341-6

Navigation